PND19 A LONG-TERM COST-EFFECTIVENESS MARKOV MODEL COMPARING DISEASE MODIFYING TREATMENTS IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS IN GERMANY
Abstract
Authors
C Plesnila-Frank N Putzki D Eheberg V Limmroth Z Katsarava SN Patel